PHARMOKINETICS (K) OF DESFERIOXAMINE (D) DURING TREATMENT OF TRANSFUSIONAL IRON OVERLOAD (IO) IN CHRONIC-HEMODIALYSIS (HD) PATIENTS

被引:0
|
作者
FOSBURG, M [1 ]
HAKIM, RM [1 ]
SCHULMAN, G [1 ]
PROPER, R [1 ]
LAZARUS, JM [1 ]
WOLFE, L [1 ]
GORIN, R [1 ]
机构
[1] HARVARD UNIV,SCH MED,BOSTON,MA 02115
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:183 / 183
页数:1
相关论文
共 24 条
  • [21] Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation
    McLeod, C.
    Fleeman, N.
    Kirkham, J.
    Bagust, A.
    Boland, A.
    Chu, P.
    Dickson, R.
    Dundar, Y.
    Greenhalgh, J.
    Modell, B.
    Olujohungbe, A.
    Telfer, P.
    Walley, T.
    HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 (01) : 1 - +
  • [22] IMPROVEMENT IN THE BLEEDING-TIME (BT) IN CHRONIC-HEMODIALYSIS (HD) PATIENTS AFTER TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN (EPO-R)
    MARTIN, FG
    CARRASCOSA, T
    ESCOBAR, EM
    HERNANDEZ, RM
    VAL, J
    DEARRIBA, G
    KIDNEY INTERNATIONAL, 1990, 37 (06) : 1608 - 1608
  • [23] Changes in iron markers and D-dimer levels during enarodustat treatment depends on different iron prescription patterns in hemodialysis patients
    Hamano, Takayuki
    Teruya, Keita
    Maruyama, Aya
    Mitobe, B. S. Yuko
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I1398 - I1399
  • [24] Changes in iron markers and D-dimer levels during enarodustat treatment depends on different iron prescription patterns in hemodialysis patients
    Hamano, Takayuki
    Teruya, Keita
    Maruyama, Aya
    Mitobe, B. S. Yuko
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39